持田製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4534/E00947 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2018/02/16 | 日証協 | 99,441株 | +0.3% | 17,819株 | +21.48% | 52,331株 | +11.09% | 12,201株 | +29.96% |
2018/02/09 | 日証協 | 99,141株 | -4.31% | 14,668株 | -74.19% | 47,106株 | -7.55% | 9,388株 | -82.08% |
2018/02/02 | 日証協 | 103,602株 | -32.59% | 56,820株 | -46% | 50,954株 | -48.98% | 52,392株 | +652.97% |
2018/01/26 | 日証協 | 153,693株 | +2.04% | 105,224株 | -10.75% | 99,864株 | +2.88% | 6,958株 | -19.69% |
2018/01/19 | 日証協 | 150,615株 | +8.97% | 117,900株 | +6.7% | 97,064株 | -3.58% | 8,664株 | +16.08% |
2018/01/12 | 日証協 | 138,215株 | +5.42% | 110,500株 | +10.61% | 100,664株 | -10.65% | 7,464株 | +63.54% |
2018/01/05 | 日証協 | 131,115株 | -0.91% | 99,900株 | +87.43% | 112,664株 | -0.18% | 4,564株 | -46.31% |
2017/12/29 | 日証協 | 132,315株 | -36.05% | 53,300株 | -1.54% | 112,864株 | -24.23% | 8,500株 | -3.01% |
2017/12/22 | 日証協 | 206,893株 | +1.04% | 54,133株 | -66.67% | 148,964株 | -0.07% | 8,764株 | -52.63% |
2017/12/15 | 日証協 | 204,757株 | +22.13% | 162,433株 | +89.08% | 149,064株 | -2.32% | 18,500株 | +28.34% |
2017/12/08 | 日証協 | 167,659株 | -5.83% | 85,907株 | -7.33% | 152,608株 | +0.17% | 14,415株 | -64.44% |
2017/12/01 | 日証協 | 178,030株 | +10.82% | 92,700株 | -2.82% | 152,350株 | +9.64% | 40,532株 | +127.71% |
2017/11/24 | 日証協 | 160,645株 | +16.92% | 95,392株 | +38.97% | 138,950株 | +10.23% | 17,800株 | +25.35% |
2017/11/17 | 日証協 | 137,397株 | +5.14% | 68,640株 | -8.58% | 126,050株 | +3.96% | 14,200株 | +36.54% |
2017/11/10 | 日証協 | 130,677株 | +25.34% | 75,084株 | +81.13% | 121,250株 | +17.6% | 10,400株 | -67.09% |
2017/11/02 | 日証協 | 104,257株 | -3.17% | 41,452株 | -15.31% | 103,102株 | -1.53% | 31,600株 | +27.12% |
2017/10/27 | 日証協 | 107,672株 | +23.13% | 48,944株 | +83.13% | 104,702株 | +14.43% | 24,858株 | +139.8% |
2017/10/20 | 日証協 | 87,445株 | +5.32% | 26,726株 | -41.15% | 91,500株 | -1.72% | 10,366株 | -70.37% |
2017/10/13 | 日証協 | 83,027株 | +28.33% | 45,412株 | +47.13% | 93,100株 | +48.48% | 34,988株 | +110.72% |
※株式分割は考慮していませんのでご注意ください。
Page Top